Figure 2

Effect of β-Asarone on the development of behavioral abnormalities after middle cerebral artery occlusion. Values are shown as means ± SEM. *p < 0.05 vs. MCAO group, **p < 0.01 vs. MCAO group. (F_SHAM =17.642, df_SHAM=11, p_SHAM=0.001, F_{β-Asarone−10}=2.252, df_{β-Asarone−10}=11, p_{β-Asarone−10}=0.162, F_{β-Asarone−20}=16.396, df_{β-Asarone−20}=11, p_{β-Asarone-20} = 0.01, F_{β-Asarone−30}=22.738, df_SHAM=11, p_SHAM=0.02).